Literature DB >> 12630412

Multipotentiality of neuronal cells after spontaneous fusion with embryonic stem cells and nuclear reprogramming in vitro.

Steve Pells1, Alexandra I Di Domenico, Ed J Gallagher, Jim McWhir.   

Abstract

Primary mouse brain cells were cultured with HPRT (hypoxanthine phosphoribosyl transferase)-deficient ES (embryonic stem) cells to see if the ES cells could provide cues sufficient to reprogram a pluripotential state. After 5 days of coculture, HPRT-deficient ES cells were killed by selection in HAT (hypoxanthine, aminopterin, thymidine) medium. We observed islands of HAT-resistant ES-like cells surrounded by differentiated cells. Cell lines generated from three such "islands" proved to be spontaneous, pluripotential ES-neural hybrids, and gave rise to a chimera following blastocyst injection. Re-expression of the ES-specific gene Foxd3 from somatic-derived chromosomes suggested that the somatic nucleus had been reprogrammed. Our results raise the intriguing possibility that ASCs shown to contribute to multiple tissues in blastocyst-injection studies may not contribute as a result of pluripotency. Instead contributions may arise from spontaneous fusion events in which phenotype is determined by either cytoplasmic dominance, nuclear reprogramming, or both.

Entities:  

Mesh:

Year:  2002        PMID: 12630412     DOI: 10.1089/153623002321025005

Source DB:  PubMed          Journal:  Cloning Stem Cells        ISSN: 1536-2302


  17 in total

1.  H3K9 histone acetylation predicts pluripotency and reprogramming capacity of ES cells.

Authors:  Hadas Hezroni; Itai Tzchori; Anna Davidi; Anna Mattout; Alva Biran; Malka Nissim-Rafinia; Heiner Westphal; Eran Meshorer
Journal:  Nucleus       Date:  2011-07-01       Impact factor: 4.197

2.  Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract.

Authors:  Christel T Freberg; John Arne Dahl; Sanna Timoskainen; Philippe Collas
Journal:  Mol Biol Cell       Date:  2007-02-21       Impact factor: 4.138

3.  Generation of somatic cell hybrids for the production of biologically active factors that stimulate proliferation of other cells.

Authors:  M Q Islam; V Panduri; K Islam
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

Review 4.  Reprogramming somatic gene activity by fusion with pluripotent cells.

Authors:  Jeong Tae Do; Dong Wook Han; Hans R Schöler
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 5.  Epigenetic reprogramming of nuclei using cell extracts.

Authors:  Philippe Collas; Christel K Taranger
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 6.  Cell fusion for reprogramming pluripotency: toward elimination of the pluripotent genome.

Authors:  Danièle Pralong; Alan O Trounson; Paul J Verma
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

7.  Maintenance of multipotency in human dermal fibroblasts treated with Xenopus laevis egg extract requires exogenous fibroblast growth factor-2.

Authors:  Denis Kole; Sakthikumar Ambady; Raymond L Page; Tanja Dominko
Journal:  Cell Reprogram       Date:  2014-01-03       Impact factor: 1.987

8.  Multiorgan engraftment and differentiation of human cord blood CD34+ Lin- cells in goats assessed by gene expression profiling.

Authors:  Fanyi Zeng; Mei-jue Chen; Don A Baldwin; Zhi-juan Gong; Jing-bin Yan; Hui Qian; Juan Wang; Xiaoyan Jiang; Zhao-rui Ren; Deming Sun; Shu-zhen Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

9.  Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells.

Authors:  Christel K Taranger; Agate Noer; Anita L Sørensen; Anne-Mari Håkelien; Andrew C Boquest; Philippe Collas
Journal:  Mol Biol Cell       Date:  2005-09-29       Impact factor: 4.138

10.  Reprogramming somatic cells by fusion with embryonic stem cells does not cause silencing of the Dlk1-Dio3 region in mice.

Authors:  Nariman R Battulin; Anna A Khabarova; Ul'yana A Boyarskikh; Aleksey G Menzorov; Maxim L Filipenko; Oleg L Serov
Journal:  World J Stem Cells       Date:  2012-08-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.